Effective drug combinations in breast, colon and pancreatic cancer cells | Nature
Proteome-wide covalent ligand discovery in native biological systems | Nature
Programmable self-regulated molecular buffers for precise sustained drug delivery | Nature Communications
Network-based approach to prediction and population-based validation of in silico drug repurposing | Nature Communications
A unified drug–target interaction prediction framework based on knowledge graph and recommendation system | Nature Communications
Improving Drug Candidates by Design: A Focus on Physicochemical Properties As a Means of Improving Compound Disposition and Safety | Chemical Research in Toxicology
Using human genetics to improve safety assessment of therapeutics | Nature Reviews Drug Discovery
Immune targets for therapeutic development in depression: towards precision medicine | Nature Reviews Drug Discovery
Avidity in antibody effector functions and biotherapeutic drug design | Nature Reviews Drug Discovery
A combined high-throughput and high-content platform for unified on-chip synthesis, characterization and biological screening | Nature Communications
Designing hydrogels for controlled drug delivery | Nature Reviews Materials
DNA-encoded chemistry: enabling the deeper sampling of chemical space | Nature Reviews Drug Discovery
The expanding role for small molecules in immuno-oncology | Nature Reviews Drug Discovery
Automating drug discovery | Nature Reviews Drug Discovery
A genome-wide positioning systems network algorithm for in silico drug repurposing | Nature Communications
Coronaviruses — drug discovery and therapeutic options | Nature Reviews Drug Discovery
Exploring protein hotspots by optimized fragment pharmacophores | Nature Communications
Counting on natural products for drug design | Nature Chemistry
The emerging role of mass spectrometry-based proteomics in drug discovery | Nature Reviews Drug Discovery
Targeting RNA structures with small molecules | Nature Reviews Drug Discovery
Bioorthogonal in situ assembly of nanomedicines as drug depots for extracellular drug delivery | Nature Communications
Synthetic prodrug design enables biocatalytic activation in mice to elicit tumor growth suppression | Nature Communications
Massively parallel de novo protein design for targeted therapeutics | Nature
Evaluating drug targets through human loss-of-function genetic variation | Nature
